<DOC>
	<DOC>NCT00133848</DOC>
	<brief_summary>The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.</brief_summary>
	<brief_title>Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment</brief_title>
	<detailed_description />
	<mesh_term>Impetigo</mesh_term>
	<criteria>Inclusion criteria: Must have primary impetigo with total lesion area being 100 square centimeters or less. Women who could bear children must have a negative urine pregnancy test and agree to either abstain from sexual intercourse or the use of specific effective contraceptive measures. Any signs and symptoms of systemic infection. Any serious underlying disease that could be imminently life threatening.</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>impetigo</keyword>
	<keyword>topical antibacterial</keyword>
	<keyword>topical antibiotic</keyword>
</DOC>